Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof

US9540666B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9540666-B2
Application numberUS-201414566458-A
CountryUS
Kind codeB2
Filing dateDec 10, 2014
Priority dateMar 19, 2009
Publication dateJan 10, 2017
Grant dateJan 10, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to isolated nucleic acid molecules and polypeptides of thraustochytrid polyunsaturated fatty acid (PUFA) synthases involved in the production of PUFAs, including PUFAs enriched in docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof. The present invention is directed to vectors and host cells comprising the nucleic acid molecules, polypeptides encoded by the nucleic acid molecules, compositions comprising the nucleic acid molecules or polypeptides, and methods of making and uses thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant nucleic acid molecule comprising a polynucleotide sequence at least 95% identical to SEQ ID NO:72 and a transcription control sequence, wherein the polynucleotide sequence encodes a polypeptide comprising beta-hydroxyacyl-ACP dehydrase (DH) activity, and enoyl-ACP reductase (ER) activity, wherein said polynucleotide sequence is heterologous to said transcription control sequence. 2. The recombinant nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the polynucleotide sequence of SEQ ID NO: 72. 3. A recombinant nucleic acid molecule comprising a polynucleotide sequence encoding a polypeptide and a transcription control sequence, wherein the polypeptide comprises an amino acid sequence at least 95% identical to SEQ ID NO: 73, wherein the polypeptide comprises beta-hydroxyacyl-ACP dehydrase (DH) activity and enoyl-ACP reductase (ER) activity, wherein said polynucleotide sequence is heterologous to said transcription control sequence. 4. The recombinant nucleic acid molecule of claim 3 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:73. 5. A host cell that expresses the nucleic acid molecule of claim 1 or claim 3 , wherein said nucleic acid molecule is heterologous to the host cell, and wherein said host cell is not a human cell. 6. The host cell of claim 5 , wherein the host cell is selected from the group consisting of a plant cell, a microbial cell, and an isolated animal cell. 7. The host cell of claim 6 , wherein the microbial cell is a thraustochytrid, excluding Thraustochytrium sp. ATCC PTA-10212. 8. The host cell of claim 7 , wherein the thraustochytrid is a Schizochytrium or a Thraustochytrium. 9. The host cell of claim 6 , wherein the plant cell is selected from the group consisting of: canola, soybean, rapeseed, linseed/flax, maize, safflower, sunflower, tobacco, Arabidopsis thaliana , Brazil nut, castor bean, coconut, coriander, cotton, groundnut, jojoba, mustard, oil palm, olive, rice, squash, barley, wheat, and duckweed. 10. A method to produce at least one PUFA, comprising: expressing a PUFA synthase gene in a host cell under conditions effective to produce PUFA, wherein the PUFA synthase gene comprises a nucleic acid molecule comprising a polynucleotide sequence at least 95% identical to SEQ ID NO:72 or a polynucleotide sequence encoding a polypeptide which comprises an amino acid sequence at least 95% identical to SEQ ID NO:73, wherein said nucleic acid molecule is heterologous to the host cell, wherein said polynucleotide sequence encodes a PUFA synthase polypeptide comprising beta-hydroxyacyl-ACP dehydrase (DH) activity and enoyl-ACP reductase (ER) activity, and wherein at least one PUFA is produced. 11. A method to produce lipids enriched for DHA, EPA, or a combination thereof, comprising: expressing a PUFA synthase gene in a host cell under conditions effective to produce lipids, wherein the PUFA synthase gene comprises a nucleic acid molecule comprising a polynucleotide sequence at least 95% identical to SEQ ID NO:72 or a polynucleotide sequence encoding a polypeptide which comprises an amino acid sequence at least 95% identical to SEQ ID NO:73, wherein said nucleic acid molecule is heterologous to the host cell, wherein said polynucleotide sequence encodes a PUFA synthase polypeptide comprising beta-hydroxyacyl-ACP dehydrase (DH) activity and enoyl-ACP reductase (ER) activity, and wherein lipids enriched with DHA, EPA, or a combination thereof are produced. 12. A method of increasing production of DHA, EPA, or a combination thereof in an organism having PUFA synthase activity, comprising: expressing the recombinant nucleic acid molecule of claim 1 or claim 3 in the organism under conditions effective to produce DHA, EPA, or a combination thereof, wherein said nucleic acid molecule is heterologous to the host organism, and wherein the PUFA synthase activity replaces an inactive or deleted activity, introduces a new activity, or enhances an existing activity in the organism, and wherein production of DHA, EPA, or a combination thereof in the organism is increased.

Assignees

Inventors

Classifications

  • Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

  • Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title

  • C12N15/52Primary

    Genes encoding for enzymes or proenzymes · CPC title

  • [Acyl-carrier-protein] S-malonyltransferase (2.3.1.39) · CPC title

  • acting on the CH-CH group of donors (1.3) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9540666B2 cover?
The present invention is directed to isolated nucleic acid molecules and polypeptides of thraustochytrid polyunsaturated fatty acid (PUFA) synthases involved in the production of PUFAs, including PUFAs enriched in docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof. The present invention is directed to vectors and host cells comprising the nucleic acid molecules, p…
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification C12N15/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).